New Releases from NCBI BookshelfEnfortumab vedotin for previously treated locally advanced or metastatic urothelial cancer (terminated appraisal).Enfortumab vedotin for previously treated locally advanced or metastatic urothelial cancer (terminated appraisal).
Post Content
